Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India flag India · Delayed Price · Currency is INR
879.00
-10.50 (-1.18%)
Feb 19, 2026, 2:10 PM IST

Jubilant Pharmova Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
140,989141,36090,43244,41861,740108,375
Market Cap Growth
-4.77%56.32%103.60%-28.06%-43.03%173.43%
Enterprise Value
163,387161,255117,28370,88182,624136,642
Last Close Price
889.50892.09564.20272.65374.10651.49
PE Ratio
32.5816.84117.29-14.9212.97
PS Ratio
1.781.951.350.711.011.78
PB Ratio
2.152.271.670.821.162.29
P/TBV Ratio
5.065.404.692.202.875.98
P/FCF Ratio
--122.87-25.998.62
P/OCF Ratio
-13.199.316.727.376.07
EV/Sales Ratio
2.062.231.751.131.352.24
EV/EBITDA Ratio
14.4315.3914.7810.977.759.31
EV/EBIT Ratio
19.3420.0722.4218.919.8411.94
EV/FCF Ratio
--159.35-34.7810.87
Debt / Equity Ratio
0.440.440.680.680.600.60
Debt / EBITDA Ratio
2.552.464.315.182.821.93
Debt / FCF Ratio
--49.78-13.442.25
Net Debt / Equity Ratio
0.340.260.500.490.410.45
Net Debt / EBITDA Ratio
2.111.573.414.122.071.46
Net Debt / FCF Ratio
--37.7636.79-17.319.271.70
Asset Turnover
-0.600.590.590.650.57
Inventory Turnover
-2.071.731.541.231.02
Quick Ratio
-1.031.181.261.341.64
Current Ratio
-1.652.052.122.212.82
Return on Equity (ROE)
-14.34%1.34%-1.21%8.21%11.09%
Return on Assets (ROA)
-4.13%2.88%2.22%5.55%6.67%
Return on Invested Capital (ROIC)
6.38%8.56%2.76%-11.24%7.64%9.50%
Return on Capital Employed (ROCE)
-7.60%5.40%4.00%10.00%14.50%
Earnings Yield
3.07%5.94%0.85%-1.37%6.70%7.71%
FCF Yield
--0.31%0.81%-3.46%3.85%11.60%
Dividend Yield
0.55%0.56%0.89%1.83%1.34%0.77%
Payout Ratio
-9.48%103.50%-19.34%0.18%
Buyback Yield / Dilution
-0.06%-0.01%0.18%0.02%0.06%0.01%
Total Shareholder Return
0.49%0.55%1.07%1.85%1.40%0.78%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.